Colgate-Palmolive Expects Profit To Decline In 2019
Colgate-Palmolive Co forecast a surprise drop in 2019 profit on Friday, blaming higher raw material costs and a stronger dollar, sending its shares down 3%. Like other consumer goods companies, the...
Colgate-Palmolive Co forecast a surprise drop in 2019 profit on Friday, blaming higher raw material costs and a stronger dollar, sending its shares down 3%.
Like other consumer goods companies, the world's largest toothpaste maker has struggled with rising commodity and transportation costs, forcing it to raise prices in regions like Latin America, where it makes the bulk of its revenue.
Higher prices crimped demand, especially in Brazil and Argentina, where Colgate faces stiff competition from Procter & Gamble's Oral-B and Unilever's Close Up.
To keep its market share, the company said it would spend more on advertising in fiscal 2019, but expects that, along with higher raw material costs and fluctuating foreign exchange rates, to lead to a mid-single-digit decline in earnings per share for the year.
Analysts were expecting a 2.4% rise in earnings per share for the year, according to IBES data from Refinitiv.
"Our outlook reflects an increase in raw material prices, an increase in our tax rate year-over-year and the uncertainty surrounding the global economy, exchange rates and pricing," Chief Executive Officer Ian Cook said in a statement.
Even in North America, where Colgate recorded strong fourth-quarter sales, economists have predicted that a consumer boom - set off by tax cuts, rising incomes and buoyant stock markets - could be fading due to a U.S. government shutdown, higher interest rates and trade tensions. The company, which boasts of a 42% share of the global toothpaste market, expects net sales for 2019 to be flat to up low-single digits, compared with analysts expectations of a 0.1% fall.
For the fourth quarter, Colgate reported an adjusted net income of $638 million, down 3% from a year earlier. On a per-share basis, it earned 74 cents, beating analysts' estimates of 73 cents.
Net sales in three months ended 31 December fell 2.1% to $3.81 billion, but beat estimates of $3.77 billion, according to Refinitiv's IBES. Shares of the company were set to open down 2.7% to $60.50 in early trading, adding to a 19% decline its stock has seen over the past 52 weeks.